PHARMACEUTICAL USE OF 2,2-BIS-THIAZOLE NON-NUCLEOSIDE COMPOUNDS AS HEPATITIS C VIRUS INHIBITOR

• 收藏
• 分享

专利权人:

SHANGHAI INSTITUTE OF MATERIA MEDICA; CHINESE ACADEMY OF SCIENCES

发明人:

NAN, FAJUN,ZUO, JIANPING,ZHANG, YANGMING,JI, FEIHONG,CHEN, HAIJUN,TONG, XIANKUN

申请号：

SG2012039095

公开号：

SG181091A1

申请日:

2010.11.24

申请国别(地区):

SG

年份:

2012

代理人:

摘要：

AbstractThe present invention discloses the pharmaceutical use of a-,2-bis-thiazolenon-nucleoside compound of formula I as an inhibitor of hepatitis C virus (HCV). The 2",2-bis-thiazole non-nucleoside compound can inhibit the replication of HCV, and thus has an anti-HCV activity and is useful for treating hepatitis C.R31N 14 *G00002*

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/